Cargando…

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Annually, influenza virus infects millions of people worldwide. Vaccination programs against seasonal influenza infections require the production of hundreds of million doses within a very short period of time. The influenza vaccine is currently produced using a technology developed in the 1940s tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milián, Ernest, Kamen, Amine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359798/ https://www.ncbi.nlm.nih.gov/pubmed/25815321 http://dx.doi.org/10.1155/2015/504831

Ejemplares similares

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
por: Thompson, Christine M, et al.
Publicado: (2013)

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
por: Youssef, Maryam, et al.
Publicado: (2023)

Critical Assessment of Purification and Analytical Technologies for Enveloped Viral Vector and Vaccine Processing and Their Current Limitations in Resolving Co-Expressed Extracellular Vesicles
por: Do Minh, Aline, et al.
Publicado: (2021)

Titration methods for rVSV-based vaccine manufacturing
por: Gélinas, Jean-François, et al.
Publicado: (2020)

Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing
por: Rajaram, Sankarasubramanian, et al.
Publicado: (2020)

Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines
por: Yang, Zeyu, et al.
Publicado: (2022)

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness
por: Rockman, Steven, et al.
Publicado: (2022)

Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture
por: Petiot, Emma, et al.
Publicado: (2011)

Vero cell upstream bioprocess development for the production of viral vectors and vaccines
por: Kiesslich, Sascha, et al.
Publicado: (2020)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Current status of red blood cell manufacturing in 3D culture and bioreactors
por: Kweon, Soonho, et al.
Publicado: (2023)

Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub-Saharan Africa
por: Farnós, Omar, et al.
Publicado: (2020)

New Technologies for Influenza Vaccines
por: Rockman, Steven, et al.
Publicado: (2020)

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
por: Yang, Zeyu, et al.
Publicado: (2023)

Vectored-Vaccine Platforms Enabled Rapid Development of Safe and Effective Vaccines in Response to COVID-19 Pandemic Situation
por: Kamen, Amine A.
Publicado: (2021)

Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
por: Fulber, Julia P. C., et al.
Publicado: (2022)

Current Status and Future Outlook of Additive Manufacturing Technologies for the Reconstruction of the Trachea
por: Lee, Hwa-Yong, et al.
Publicado: (2023)

Only a small fraction of cells produce assembled capsids during transfection‐based manufacturing of adeno‐associated virus vectors
por: Dash, Shantoshini, et al.
Publicado: (2022)

Platform technologies for modern vaccine manufacturing
por: Charlton Hume, Hayley K., et al.
Publicado: (2017)

Industrial controls and manufacturing
por: Kamen, Edward W
Publicado: (1999)

Emerging Vaccine Technologies
por: Loomis, Rebecca J., et al.
Publicado: (2015)

Review of Plastic Surgery Biomaterials and Current Progress in Their 3D Manufacturing Technology
por: Peng, Wei, et al.
Publicado: (2020)

Comparative Transcriptomic Analyses of a Vero Cell Line in Suspension versus Adherent Culture Conditions
por: Sène, Marie-Angélique, et al.
Publicado: (2023)

Optimization and scale-up of cell culture and purification processes for production of an adenovirus-based tuberculosis vaccine
por: Shen, Chun F, et al.
Publicado: (2015)

Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures
por: Fulber, Julia Puppin Chaves, et al.
Publicado: (2021)

A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms
por: Sharon, David M., et al.
Publicado: (2020)

Bioartificial Organ Manufacturing Technologies
por: Wang, Xiaohong
Publicado: (2018)

Cellular signaling pathways modulated by influenza infection in HEK293 cells
por: Manceur, Aziza P, et al.
Publicado: (2015)

Current and Emerging Technology for Continuous Glucose Monitoring
por: Chen, Cheng, et al.
Publicado: (2017)

Mpox diagnostics: Review of current and emerging technologies
por: Lim, Chuan Kok, et al.
Publicado: (2023)

A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses
por: Baras, Benoit, et al.
Publicado: (2008)

An evaluation of the emerging vaccines against influenza in children
por: Nair, Harish, et al.
Publicado: (2013)

Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020)

Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
por: Kiesslich, Sascha, et al.
Publicado: (2021)

Screen‐Printing Technology for Scale Manufacturing of Perovskite Solar Cells
por: Chen, Changshun, et al.
Publicado: (2023)

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing
por: Donis, Ruben O., et al.
Publicado: (2014)

Editorial for the Special Issue on Emerging Micro Manufacturing Technologies and Applications
por: Tapoglou, Nikolaos
Publicado: (2023)

Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery
por: Chahal, Parminder Singh, et al.
Publicado: (2014)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
por: Ambrose, Christopher S., et al.
Publicado: (2008)

Research Progress of Arc Additive Manufacture Technology
por: Liu, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35rnvr1lqbr0bl5fv9r12mirtf